Medicare Enrolled
Dr. Elisabeth McKeen, M.D.
Medical Oncology · Palm Beach Gardens, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McKeen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McKeen? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McKeen
Dr. Elisabeth McKeen is a medical oncology in Palm Beach Gardens, FL, with 20 years in practice. Based on federal Medicare data, Dr. McKeen performed 32,016 Medicare services across 4,651 unique beneficiaries.
Between the years covered by Open Payments, Dr. McKeen received a total of $22,226 from 101 pharmaceutical and/or device companies across 1286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McKeen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 39% volume in FL$ $22,226 industry payments
Medicare Practice Summary
Medicare Utilization ↗32,016
Medicare services
Top 39% in FL for medical oncology
4,651
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,601 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 8,340 | $18 | $51 |
| Contrast dye for imaging (iodine-based) | 7,372 | $0 | $1 |
| Injection, fulvestrant, 25 mg | 4,190 | $8 | $132 |
| Complete blood count (CBC) with differential | 2,520 | $8 | $29 |
| Blood draw (venipuncture) | 2,211 | $8 | $9 |
| Office visit, established patient (30-39 min) | 1,720 | $97 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,230 | $1 | $28 |
| Dexamethasone injection (steroid) | 1,164 | $0 | $3 |
| Office visit, established patient (20-29 min) | 753 | $67 | $239 |
| Drug injection, under skin or into muscle | 464 | $10 | $69 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 402 | $26 | $89 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 304 | $1 | $6 |
| Injection of additional new drug or substance into vein | 223 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 186 | $103 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 162 | $23 | $84 |
| Injection, zoledronic acid, 1 mg | 136 | $7 | $69 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 99 | $400 | $680 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 96 | $1,161 | $3,706 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 74 | $51 | $189 |
| CT scan of abdomen and pelvis with contrast | 62 | $172 | $550 |
| Ct scan of chest with contrast | 61 | $57 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 56 | $1 | $3 |
| Automated urinalysis | 40 | $2 | $8 |
| Administration of chemotherapy into vein, each additional hour | 35 | $23 | $79 |
| New patient office visit (45-59 min) | 30 | $131 | $453 |
| CT scan of chest, without contrast | 23 | $59 | $350 |
| Echocardiogram, transthoracic | 21 | $97 | $430 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $17 | $59 |
| Office visit, established patient, complex (40-54 min) | 21 | $138 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
76.0% medium
23.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,226
Total received (2018-2024)
Avg $3,175/year across 7 years
Top 24% in FL for medical oncology
101
Companies
1,286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,792 (89.1%)
Other
Charitable contributions, space rental, and other categories
$2,032 (9.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$402 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,443
2023$4,617
2022$2,809
2021$2,082
2020$2,311
2019$2,570
2018$3,395
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,758
AstraZeneca Pharmaceuticals LP
$1,319
Celgene Corporation
$1,220
PFIZER INC.
$1,029
Daiichi Sankyo Inc.
$965
Lilly USA, LLC
$877
Janssen Biotech, Inc.
$845
E.R. Squibb & Sons, L.L.C.
$813
Seagen Inc.
$745
Amgen Inc.
$715
NanoString Technologies, Inc.
$619
Astellas Pharma US Inc
$499
Genentech USA, Inc.
$489
Merck Sharp & Dohme LLC
$443
Eisai Inc.
$427
Incyte Corporation
$396
Pharmacyclics LLC, An AbbVie Company
$352
ABBVIE INC.
$333
Bayer HealthCare Pharmaceuticals Inc.
$329
GlaxoSmithKline, LLC.
$314
GENZYME CORPORATION
$304
NOVARTIS PHARMACEUTICALS CORPORATION
$303
Ipsen Biopharmaceuticals, Inc
$290
Takeda Pharmaceuticals U.S.A., Inc.
$285
Seattle Genetics, Inc.
$280
Merck Sharp & Dohme Corporation
$271
Puma Biotechnology, Inc.
$261
PUMA BIOTECHNOLOGY, INC.
$212
Tempus AI, Inc
$200
Kyowa Kirin, Inc.
$195
Alexion Pharmaceuticals, Inc.
$184
Exelixis Inc.
$149
Bayer Healthcare Pharmaceuticals Inc.
$148
Gilead Sciences, Inc.
$147
Taiho Oncology, Inc.
$134
Heron Therapeutics, Inc.
$128
ARRAY BIOPHARMA INC
$127
Foundation Medicine, Inc.
$119
Deciphera Pharmaceuticals Inc.
$116
TerSera Therapeutics LLC
$115
Dendreon Pharmaceuticals LLC
$111
Stemline Therapeutics Inc.
$107
RECORDATI_RARE_DISEASES_INC.
$107
SERVIER PHARMACEUTICALS LLC
$103
Clovis Oncology, Inc.
$102
PharmaEssentia USA Corporation
$98
EISAI INC.
$96
Dova Pharmaceuticals
$93
HOLOGIC INC
$92
Regeneron Healthcare Solutions, Inc.
$86
Adaptive Biotechnologies Corporation
$84
Pharmacyclics LLC, an AbbVie Company
$84
TESARO, Inc.
$79
Kite Pharma, Inc.
$75
Agios Pharmaceuticals, Inc.
$74
Shire North American Group Inc
$71
AVEO Pharmaceuticals, Inc.
$69
Aurobindo Pharma USA, Inc.
$66
Myriad Genetic Laboratories, Inc.
$60
Octapharma USA, Inc.
$59
JAZZ PHARMACEUTICALS INC.
$56
Alnylam Pharmaceuticals Inc.
$46
Global Blood Therapeutics, Inc.
$46
Emmaus Medical, Inc.
$45
BeiGene USA, Inc.
$44
Mirati Therapeutics, Inc.
$43
SOBI, INC
$39
Sobi, Inc
$39
AbbVie Inc.
$38
ImmunoGen, Inc.
$36
CTI BioPharma Corp.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
TAIHO ONCOLOGY, INC.
$29
EMD Serono, Inc.
$29
Shield Therapeutics Inc
$25
Karyopharm Therapeutics Inc.
$25
Biocon Biologics Inc
$24
MorphoSys, US Inc.
$24
Spectrum Pharmaceuticals Inc.
$24
Otsuka America Pharmaceutical, Inc.
$23
Pharmacosmos Therapeutics Inc.
$23
Teva Pharmaceuticals USA, Inc.
$22
Sun Pharmaceutical Industries Inc.
$22
Immunocore Limited
$21
AbbVie, Inc.
$21
EUSA Pharma (US) LLC
$21
Azurity Pharmaceuticals, Inc.
$19
Acrotech Biopharma Inc.
$19
Sirtex Medical Inc
$18
Blue Earth Diagnostics Limited
$17
Helsinn Therapeutics (U.S.), Inc.
$17
Acrotech Biopharma LLC
$17
Medtronic Vascular, Inc.
$16
R-Pharm US LLC
$16
Cumberland Pharmaceuticals, Inc.
$15
GE HealthCare
$15
ORGANOGENESIS INC.
$14
Tactile Systems Technology Inc
$12
Fortovia Therapeutics, Inc.
$11
Veracyte, Inc.
$10
Organon LLC
$7
Top 3 companies account for 23.8% of total payments
Associated products mentioned in payments ›
6 · ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CINVANTI · CYRAMZA · Cabometyx · Cerianna · Cinvanti · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Endari · Enhertu · FARESTON · FASLODEX · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · Fulphila · GAMMAGARD · GAZYVA · GILOTRIF · GIVLAARI · Halaven · HawkOne · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · PreciseTumor · Prolia · Puraply · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VONVENDI · VOTRIENT · VPRIV · Vectibix · Venclexta · Vitrakvi · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XGEVA · XPOVIO · XT CDX · XTANDI · Xofigo · Xtandi · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $69 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
18
Per 100K population
1.2
County median income
$81,115
Nearest hospital
PALM BEACH GARDENS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McKeen is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McKeen experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. McKeen performed 8,340 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McKeen receive payments from pharmaceutical companies?
Yes. Dr. McKeen received a total of $22,226 from 101 companies across 1,286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McKeen's costs compare to other medical oncologys in Palm Beach Gardens?
Dr. McKeen's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McKeen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Palm Beach Gardens
Browse medical oncologys in Palm Beach Gardens ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology